Exact Mass: 470.1559
Exact Mass Matches: 470.1559
Found 220 metabolites which its exact mass value is equals to given mass value 470.1559
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
3-Carboxylic acid-picumast
Alvaradoin M
A C-glycosyl compound that is 1,8-dihydroxy-3-methylanthracen-9(10H)-one substituted by a 3-O-senecioyl-alpha-L-lyxopyranosyl moiety at position 10 via a C-glycosidic linkage (the 10S stereoisomer). It is isolated from the leaves of Alvaradoa haitiensis and exhibits cytotoxicity against human oral epidermoid carcinoma.
Alvaradoin L
A C-glycosyl compound that is 1,8-dihydroxy-3-methylanthracen-9(10H)-one substituted by a 2-O-senecioyl-alpha-lyxopyranosyl moiety at position 10 via a C-glycosidic linkage (the 10S stereoisomer). It is isolated from the leaves of Alvaradoa haitiensis and exhibits cytotoxicity against human oral epidermoid carcinoma.
2-(1,3-Benzodioxol-5-yl)-3,5,6,8-tetramethoxy-7-[(3-methyl-2-butenyl)oxy]-4H-1-benzopyran-4-one
Ala Cys Asp Tyr
Ala Cys Phe Met
Ala Cys Met Phe
Ala Cys Tyr Asp
Ala Asp Cys Tyr
Ala Asp Tyr Cys
Ala Phe Cys Met
Ala Phe Met Cys
Ala Met Cys Phe
Ala Met Phe Cys
Ala Tyr Cys Asp
Ala Tyr Asp Cys
Cys Ala Asp Tyr
Cys Ala Phe Met
Cys Ala Met Phe
Cys Ala Tyr Asp
Cys Cys Phe Val
Cys Cys Val Phe
Cys Asp Ala Tyr
Cys Asp Phe Ser
Cys Asp His Pro
Cys Asp Pro His
Cys Asp Ser Phe
Cys Asp Tyr Ala
Cys Glu Gly Tyr
Cys Glu Tyr Gly
Cys Phe Ala Met
Cys Phe Cys Val
Cys Phe Asp Ser
Cys Phe Met Ala
Cys Phe Ser Asp
Cys Phe Val Cys
Cys Gly Glu Tyr
Cys Gly Tyr Glu
Cys His Asp Pro
Cys His Pro Asp
Cys Met Ala Phe
Cys Met Phe Ala
Cys Pro Asp His
Cys Pro His Asp
Cys Ser Asp Phe
Cys Ser Phe Asp
Cys Val Cys Phe
Cys Val Phe Cys
Cys Tyr Ala Asp
Cys Tyr Asp Ala
Cys Tyr Glu Gly
Cys Tyr Gly Glu
Asp Ala Cys Tyr
Asp Ala Tyr Cys
Asp Cys Ala Tyr
Asp Cys Phe Ser
Asp Cys His Pro
Asp Cys Pro His
Asp Cys Ser Phe
Asp Cys Tyr Ala
Asp Phe Cys Ser
Asp Phe Ser Cys
Asp His Cys Pro
Asp His Pro Cys
Asp Pro Cys His
Asp Pro His Cys
Asp Ser Cys Phe
Asp Ser Phe Cys
Asp Ser Ser Tyr
Asp Ser Tyr Ser
Asp Tyr Ala Cys
Asp Tyr Cys Ala
Asp Tyr Ser Ser
Glu Cys Gly Tyr
Glu Cys Tyr Gly
Glu Gly Cys Tyr
Glu Gly Tyr Cys
Glu Tyr Cys Gly
Glu Tyr Gly Cys
Phe Ala Cys Met
Phe Ala Met Cys
Phe Cys Ala Met
Phe Cys Cys Val
Phe Cys Asp Ser
Phe Cys Met Ala
Phe Cys Ser Asp
Phe Cys Val Cys
Phe Asp Cys Ser
Phe Asp Ser Cys
Phe Met Ala Cys
Phe Met Cys Ala
Phe Ser Cys Asp
Phe Ser Asp Cys
Phe Val Cys Cys
Gly Cys Glu Tyr
Gly Cys Tyr Glu
Gly Glu Cys Tyr
Gly Glu Tyr Cys
Gly Tyr Cys Glu
Gly Tyr Glu Cys
His Cys Asp Pro
His Cys Pro Asp
His Asp Cys Pro
His Asp Pro Cys
His Pro Cys Asp
His Pro Asp Cys
Met Ala Cys Phe
Met Ala Phe Cys
Met Cys Ala Phe
Met Cys Phe Ala
Met Phe Ala Cys
Met Phe Cys Ala
Pro Cys Asp His
Pro Cys His Asp
Pro Asp Cys His
Pro Asp His Cys
Pro His Cys Asp
Pro His Asp Cys
Ser Cys Asp Phe
Ser Cys Phe Asp
Ser Asp Cys Phe
Ser Asp Phe Cys
Ser Asp Ser Tyr
Ser Asp Tyr Ser
Ser Phe Cys Asp
Ser Phe Asp Cys
Ser Ser Asp Tyr
Ser Ser Tyr Asp
Ser Tyr Asp Ser
Ser Tyr Ser Asp
Val Cys Cys Phe
Val Cys Phe Cys
Val Phe Cys Cys
Tyr Ala Cys Asp
Tyr Ala Asp Cys
Tyr Cys Ala Asp
Tyr Cys Asp Ala
Tyr Cys Glu Gly
Tyr Cys Gly Glu
Tyr Asp Ala Cys
Tyr Asp Cys Ala
Tyr Asp Ser Ser
Tyr Glu Cys Gly
Tyr Glu Gly Cys
Tyr Gly Cys Glu
Tyr Gly Glu Cys
Tyr Ser Asp Ser
Tyr Ser Ser Asp
1-[[2-(2,5-Dihydro-5-oxo-1,2,4-oxadiazol-3-yl)[1,1-biphenyl]-4-yl]methyl]-2-ethoxy-1H-benzimidazole-7-carboxylic acid methyl ester
7-[2-(1,3-Benzothiazol-2-ylthio)ethyl]-1,3-dimethyl-8-(3-methyl-1-piperidinyl)purine-2,6-dione
N-(2-furanylmethyl)-2-[[oxo-(3,4,5-trimethoxyphenyl)methyl]amino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide
Alvaradoin K
A C-glycosyl compound that is 1,8-dihydroxy-3-methylanthracen-9(10H)-one substituted by a 2-O-senecioyl-alpha-lyxopyranosyl moiety at position 10 via a C-glycosidic linkage (the 10R stereoisomer). It is isolated from the leaves of Alvaradoa haitiensis and exhibits cytotoxicity against human oral epidermoid carcinoma.
3-[2-(tert-butylamino)-2-oxoethoxy]-N-(4-chloro-2,5-dimethoxyphenyl)-2-naphthalenecarboxamide
4-(3,5-dimethyl-1-pyrazolyl)-N-[2-methoxy-5-(4-morpholinylsulfonyl)phenyl]benzamide
(2S)-3-(1H-indol-3-yl)-2-[[2-(4-methyl-6-oxobenzo[c]chromen-3-yl)oxyacetyl]amino]propanoic acid
N-[[(4S,5S)-8-(2-cyclopropylethynyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylmethanesulfonamide
N-[[(4S,5S)-8-(2-cyclopropylethynyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylmethanesulfonamide
N-[[(4R,5S)-8-(2-cyclopropylethynyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylmethanesulfonamide
N-[[(4R,5R)-8-(2-cyclopropylethynyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylmethanesulfonamide
N-[[(4R,5S)-8-(2-cyclopropylethynyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylmethanesulfonamide
N-[[(4S,5R)-8-(2-cyclopropylethynyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylmethanesulfonamide
N-[[(4R,5R)-8-(2-cyclopropylethynyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylmethanesulfonamide
N-[[(4S,5R)-8-(2-cyclopropylethynyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylmethanesulfonamide
methyl 2-[(5E)-5-[(3,4-diethoxyphenyl)methylidene]-3-(4-methoxyphenyl)-4-oxo-2-sulfanylideneimidazolidin-1-yl]acetate
[(2->6)-alpha-D-glucosyl-(1->4)-N-acetyl-alpha-D-neuraminosyl]n
AZD1283
AZD1283 is a potent P2Y12 receptor antagonist with a binding IC50 of 11 nM and a GTPγS IC50 of 25 nM. AZD1283 has excellent antiplatelet aggregation potency. AZD1283 can be used to research thromboembolic disorders[1][2].